Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

37.50$ +0.6% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Novo Nordisk A/S (NVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 309,064 million DKK. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of DKK.

Tick rows to compare them in a chart (up to 4)

Income Statement NVO
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	14,904	16,984	13,649	16,442	20,815	23,717	25,154	26,613	29,234	33,714	38,752	41,889	45,666	51,078	60,776	66,346	78,026	83,572	88,806	107,927	111,780	111,696	111,831	122,021	126,946	140,800	176,954	232,261	290,403	309,064
Cost of Revenue	4,167	4,722	3,216	3,630	4,380	5,965	6,625	7,462	8,105	9,166	9,589	9,804	10,131	10,438	11,680	12,589	13,465	14,140	14,562	16,188	17,183	17,632	17,617	20,088	20,932	23,658	28,448	35,765	44,522	58,788
Gross Profit	10,737	12,262	10,432	12,812	16,435	17,752	18,529	19,151	21,128	24,548	29,163	32,085	35,535	40,640	49,096	53,757	64,561	69,432	74,244	91,739	94,597	94,064	94,214	101,933	106,014	117,142	148,506	196,496	245,881	250,276
Research & Development	–	2,770	2,650	2,588	3,225	3,960	4,133	4,204	4,385	5,075	6,317	8,551	7,874	7,864	9,602	9,628	10,897	11,733	13,762	13,608	14,563	14,014	14,805	14,220	15,462	17,772	24,047	32,443	48,062	52,039
Selling, General & Administrative	7,689	6,016	6,589	7,497	7,933	9,056	9,420	9,673	10,295	11,795	13,997	14,897	15,823	2,764	3,065	3,245	3,312	3,508	3,537	3,857	3,962	3,784	3,916	4,007	3,958	4,050	4,467	4,855	5,276	5,969
Total Operating Expenses	8,757	9,928	8,999	9,892	12,192	12,155	12,556	12,748	14,098	16,472	20,043	23,131	23,130	25,707	30,205	31,383	35,087	37,939	39,752	42,295	46,165	45,097	46,966	49,450	51,888	58,498	73,697	93,922	117,542	122,618
Operating Income	1,980	2,334	1,433	2,920	4,243	5,597	5,974	6,403	7,030	8,075	9,120	8,955	12,405	14,933	18,891	22,374	29,474	31,493	34,492	49,444	48,432	48,967	47,248	52,483	54,126	58,644	74,809	102,574	128,339	127,658
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1,265	500	275	58	55	39	67	65	90	85	220	390	289	378	542	1,640	4,207
Pre-Tax Income	2,529	3,172	3,178	3,356	4,845	6,015	6,292	7,580	7,507	8,220	9,165	10,985	12,726	13,988	18,286	21,925	27,811	32,539	34,096	43,483	47,798	48,680	47,615	48,553	53,130	59,080	69,062	104,674	127,191	130,540
Income Tax Expense	727	952	1,159	1,353	1,757	2,164	2,201	2,531	2,459	2,364	2,712	2,455	3,060	3,220	3,883	4,828	6,379	7,355	7,615	8,623	9,873	10,550	8,987	9,602	10,992	11,323	13,537	20,991	26,203	28,106
Net Income	1,803	2,219	2,414	2,418	3,088	3,851	4,091	4,872	5,049	5,856	6,453	8,535	9,666	10,768	14,403	17,097	21,432	25,184	26,481	34,860	37,925	38,130	38,628	38,951	42,138	47,757	55,525	83,683	100,988	102,434
EBITDA	3,048	3,476	2,420	3,867	5,278	6,675	7,304	8,024	8,934	10,004	11,262	11,972	14,860	17,804	21,253	24,937	30,562	35,393	37,570	46,509	51,056	51,952	51,625	54,434	59,273	65,394	76,802	114,629	147,938	156,729

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings